Stellantis N.V. (STLA)

Stellantis N.V. shares closed at $4.26 after falling 3.62% in the last session, and the stock sits near the bottom of its 52-week range, 4% of the way up from the $3.92 low toward the $12.22 high. The decline has been steady over the past year, down 58.88%, and the stock is below its 50-day and 200-day moving averages ($4.67 and $6.39). The October 28, 2026 report gave the one clear bright spot: adjusted EPS of -$0.01 beat the -$0.18 estimate by 94.44%, and the shares rose 13.04% in the next session. The stock still carries a CleaRank rating of Sell, and the earlier earnings miss and rating cuts explain much of the caution around it.

Stellantis reported adjusted EPS of -$0.01 on October 28, 2026, against an analyst estimate of -$0.18, a beat of 94.44%. The shares rose 13.04% in the first session after the report, the largest one-day gain shown in the earnings record. The beat is the strongest data point in the company's recent results, but it came after a sharp miss on July 30, 2026, when EPS of $0.14 fell 65.00% short of the $0.40 estimate, and the stock fell 2.50% that day. Of the four recent reports, three beat the estimate, and two of those three beats were followed by a lower share price, which shows how weakly earnings surprises have translated into sustained buying.

The stock is 8.72% below its 50-day average and 33.29% below its 200-day average, and the 50-day average itself sits 26.91% below the 200-day average. Shares have fallen 42.43% over six months and 58.88% over the past year. The MACD line is negative and the 14-day RSI of 42.5 is in the neutral zone, so momentum has not yet turned, even though the price has held above its 52-week low. Last session volume was 22.0% below its average, which suggests the drop on that day was not driven by heavy selling.

The net profit margin is -9.55%, the operating margin is -0.59%, and return on equity is -26.48%, well below the sector median of 12.4%. The debt-to-equity ratio of 0.91 is moderate. Trailing GAAP EPS is -$6.25, so the P/E ratio is not meaningful.

Of seven analysts with a current rating, three rate the stock buy or strong buy, one holds, and three sell or strong sell, which gives a consensus of Hold. Three months ago, three of ten ratings were buy. Freedom Broker kept its Buy rating on October 13, 2026, while UBS downgraded the stock to Neutral from Buy on August 3, 2026, and JP Morgan downgraded it to Neutral from Overweight on July 9, 2026. TD Cowen kept its Hold rating on July 13, 2026. Analysts expect revenue of $161.2B this fiscal year, up 5.0%.

The base case for the coming months is that the stock stays under pressure while it trades below its 200-day average of $6.39 and its 50-day average of $4.67. A recovery toward the 50-day average would need the price to hold above the 20-day EMA of $4.46 on steady volume, and the one-day jump after the October report shows how quickly sentiment can shift when results beat expectations. Analysts' median 12-month target of $6.32 sits 48.2% above the price, with a range from $4.00 to $10.00, but the analyst split is three buy, one hold and three sell ratings, and three of the four recent rating actions were cuts or holds rather than upgrades. Upside would require sustained earnings beats and an improving trend. The risk to the base case is a break below the 52-week low of $3.92, which would put the stock at new lows. Analysts expect EPS to rise from $0.49 this fiscal year to $1.20 next year, but that growth depends on the company delivering it.

Support sits at the 52-week low of $3.92, the only level below the price and the line the stock would meet first on a fall. Resistance begins at the 20-day EMA of $4.46, the nearest level above the price, which a rise would meet first. Next is the 50-day simple moving average at $4.67, then the 200-day simple moving average at $6.39, which the stock would need to clear to reverse its longer-term downtrend. The 52-week high of $12.22 is the far ceiling and would require a sustained rally to reach.